C. W. Duinkerken

Sensorineural Hearing Loss After Adoptive Cell Immunotherapy for Melanoma Using MART-1 Specific T Cells: A Case Report and Its Pathophysiology.

W. Dreschler, J. Haanen, A. Balm, 2019, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

Transtympanic Sodium Thiosulfate for Prevention of Cisplatin-Induced Ototoxicity: A Randomized Clinical Trial

W. Dreschler, M. Hauptmann, J. Schellens, 2021, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

Orthovoltage for basal cell carcinoma of the head and neck: Excellent local control and low toxicity profile

A. Al-Mamgani, F. Balm, B. Zupan-Kajcovski, 2016, The Laryngoscope.

Orthovoltage X-rays for Postoperative Treatment of Resected Basal Cell Carcinoma in the Head and Neck Area

R. Haas, A. Al-Mamgani, M. Crijns, 2017, Journal of cutaneous medicine and surgery.

MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial

C. Blank, R. de Boer, J. Haanen, 2022, Immuno-Oncology Technology.

The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin-based chemoradiotherapy in patients with head and neck squamous cell carcinoma.

L. van der Molen, A. Al-Mamgani, L. Devriese, 2024, Head & neck.